Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fermagate in Hyperphosphataemia in Haemodialysis Patients
NCT00317694Phase 2Completed
- Sponsor
- INEOS Healthcare Limited
- Start
- Mar 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in hyperphosphatemia comparing Fermagate with Placebo (2 arms). Primary endpoint: Proportion of subjects who achieve controlled serum phosphate concentrations. Started Mar 2006; status: completed.
02
Drugs
fermagate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00317694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317694.